Skip to main content
Top
Published in: Indian Journal of Hematology and Blood Transfusion 1/2024

Open Access 08-07-2023 | ORIGINAL ARTICLE

Analysis of Rhesus (Rh) Antigen Distributions in Donors and Multi-transfused Patients for Phenotype-Matched Transfusion

Authors: Yuhong Zhao, Ni Yao, Yan Lv, Dawei Cui, Jue Xie

Published in: Indian Journal of Hematology and Blood Transfusion | Issue 1/2024

Login to get access

Abstract

Knowledge about the frequency of Rh blood group systems in the local population help build a donor pool for multi-transfused patients and provide antigen-negative compatible blood for patients with alloantibodies. ABO and Rh antigens were identified for blood donors and patients before transfusion. The antiglobulin test based on the micro-column gel method was used to perform unexpected antibody screening and identification for patients in pre-transfusion testing. The incidence of the adverse transfusion reactions and the accordance rate of Rh phenotype-matched transfusion were analyzed retrospectively. A total of 246,340 specimens were detected with Rh blood group antigens D, C, E, c, and e. Rh D antigen was the most common phenotype with a frequency of 99.40%, followed by e antigen, C antigen, c antigen, and E antigen. In Rh D positive specimens, DCe was the most common phenotype, while DCE was the least common. At the same time, in Rh D negative specimens, ce was the most common phenotype with CE and CcE unobserved. Rh phenotype-matched transfusion has been conducted in our department since 2012. The accordance rate of Rh phenotype-matched transfusion has been kept above 95% and the resulting incidence of adverse transfusion reactions has been decreasing year by year, from 19.95‰ in 2011 to 2.21‰ in 2021. Blood transfusion with matched Rh phenotypes was able to avoid the generation of unexpected antibodies, reduce the incidence of adverse transfusion reactions, and enhance precise diagnosis and treatment.
Appendix
Available only for authorised users
Literature
1.
go back to reference Daniels G, Castilho L, Flegel WA, Fletcher A, Garratty G, Levene C et al (2009) International Society of Blood Transfusion Committee on terminology for red cell surface antigens: macao report. Vox Sang 96:153–156CrossRefPubMed Daniels G, Castilho L, Flegel WA, Fletcher A, Garratty G, Levene C et al (2009) International Society of Blood Transfusion Committee on terminology for red cell surface antigens: macao report. Vox Sang 96:153–156CrossRefPubMed
2.
go back to reference Westhoff CM (2004) The Rh blood group system in review: a new face for the next decade. Transfusion 44:1663–1673CrossRefPubMed Westhoff CM (2004) The Rh blood group system in review: a new face for the next decade. Transfusion 44:1663–1673CrossRefPubMed
3.
go back to reference Wagner FE, Moulds JM, Flegel WA (2005) Genetic mechanisms of Rhesus box variation. Transfusion 45:338–344CrossRefPubMed Wagner FE, Moulds JM, Flegel WA (2005) Genetic mechanisms of Rhesus box variation. Transfusion 45:338–344CrossRefPubMed
4.
go back to reference Gupta R, Singh DK, Singh B, Rusia U (2011) Alloimmunization to red cells in thalassemics: emerging problem and future strategies. Transfus Apher Sci 45:167–170CrossRefPubMed Gupta R, Singh DK, Singh B, Rusia U (2011) Alloimmunization to red cells in thalassemics: emerging problem and future strategies. Transfus Apher Sci 45:167–170CrossRefPubMed
5.
go back to reference Pahuja S, Pujani M, Gupta SK, Chandra J, Jain M (2010) Alloimmunization and red cell autoimmunization in multitransfused thalassemics of Indian origin. Hematology 1:174–177CrossRef Pahuja S, Pujani M, Gupta SK, Chandra J, Jain M (2010) Alloimmunization and red cell autoimmunization in multitransfused thalassemics of Indian origin. Hematology 1:174–177CrossRef
6.
go back to reference Chou ST, Jackson T, Vege S, Smith-Whitley K, Friedman DF, Westhoff CM (2013) High prevalence of red blood cell alloimmunization in sickle cell disease despite transfusion from Rh-matched minority donors. Blood 122:1062–1071CrossRefPubMed Chou ST, Jackson T, Vege S, Smith-Whitley K, Friedman DF, Westhoff CM (2013) High prevalence of red blood cell alloimmunization in sickle cell disease despite transfusion from Rh-matched minority donors. Blood 122:1062–1071CrossRefPubMed
8.
go back to reference Osman NH, Sathar J, Leong CF, Zulkifli NF, Raja Sabudin RZ, Othman A et al (2017) Importance of extended blood group genotyping in multiply transfused patients. Transfus Apher Sci 56:410–416CrossRefPubMed Osman NH, Sathar J, Leong CF, Zulkifli NF, Raja Sabudin RZ, Othman A et al (2017) Importance of extended blood group genotyping in multiply transfused patients. Transfus Apher Sci 56:410–416CrossRefPubMed
9.
go back to reference Vichinsky EP, Luban NL, Wright E, Olivieri N, Driscoll C, Pegelow CH et al (2001) Prospective RBC phenotype matching in a stroke-prevention trial in sickle cell anemia: a multicenter transfusion trial. Transfusion 4:1086–1092CrossRef Vichinsky EP, Luban NL, Wright E, Olivieri N, Driscoll C, Pegelow CH et al (2001) Prospective RBC phenotype matching in a stroke-prevention trial in sickle cell anemia: a multicenter transfusion trial. Transfusion 4:1086–1092CrossRef
10.
go back to reference Nathalang O, Kuvanont S, Punyaprasiddhi P, Tasaniyanonda C, Sriphaisal T (2001) A preliminary study of the distribution of blood group systems in Thai blood donors determined by the gel test. Southeast Asian J Trop Med Public Health 32:204–207PubMed Nathalang O, Kuvanont S, Punyaprasiddhi P, Tasaniyanonda C, Sriphaisal T (2001) A preliminary study of the distribution of blood group systems in Thai blood donors determined by the gel test. Southeast Asian J Trop Med Public Health 32:204–207PubMed
11.
go back to reference Fischbach F (2002) Nurses’ quick reference to common laboratory and diagnostic tests, 3rd edn. Lippincott, Philadelphia, PA, US, pp 19–25 Fischbach F (2002) Nurses’ quick reference to common laboratory and diagnostic tests, 3rd edn. Lippincott, Philadelphia, PA, US, pp 19–25
12.
go back to reference Nanu A, Thapliyal RM (1997) Blood group gene frequency in a selected north Indian population. Indian J Med Res 106:242–246PubMed Nanu A, Thapliyal RM (1997) Blood group gene frequency in a selected north Indian population. Indian J Med Res 106:242–246PubMed
14.
15.
go back to reference Davies SC, McWilliam AC, Hewitt PE, Devenish A, Brozovic M (1986) Red cell alloimmunization in sickle cell disease. Br J Haematol 63:241–245CrossRefPubMed Davies SC, McWilliam AC, Hewitt PE, Devenish A, Brozovic M (1986) Red cell alloimmunization in sickle cell disease. Br J Haematol 63:241–245CrossRefPubMed
16.
go back to reference Lamba DS, Kaur R, Basu S (2013) Clinically significant minor blood group antigens amongst North Indian donor population. Adv Haematol 2013:215454 Lamba DS, Kaur R, Basu S (2013) Clinically significant minor blood group antigens amongst North Indian donor population. Adv Haematol 2013:215454
17.
go back to reference Musa RH, Ahmed SA, Hashim H, Ayob Y, Asidin NH, Choo PY et al (2012) Red cell phenotyping of blood from donors at the National blood center of Malaysia. Asian J Transfus Sci 6:3–9CrossRefPubMedPubMedCentral Musa RH, Ahmed SA, Hashim H, Ayob Y, Asidin NH, Choo PY et al (2012) Red cell phenotyping of blood from donors at the National blood center of Malaysia. Asian J Transfus Sci 6:3–9CrossRefPubMedPubMedCentral
18.
go back to reference Dhawan HK, Kumawat V, Marwaha N, Sharma RR, Sachdev S, Bansal D et al (2014) Alloimmunization and autoimmunization in transfusion dependent thalassemia major patients: study on 319 patients. Asian J Transfus Sci 8:84–88CrossRefPubMedPubMedCentral Dhawan HK, Kumawat V, Marwaha N, Sharma RR, Sachdev S, Bansal D et al (2014) Alloimmunization and autoimmunization in transfusion dependent thalassemia major patients: study on 319 patients. Asian J Transfus Sci 8:84–88CrossRefPubMedPubMedCentral
19.
go back to reference Agnihotri A (2014) Antibody screening with the Asian cell panel: can we still do away with cross-match? Abstract of 2nd Indian Society of Transfusion Medicine (ISTM) annual conference. Asian J Transfus Sci 8(S1):26–87 Agnihotri A (2014) Antibody screening with the Asian cell panel: can we still do away with cross-match? Abstract of 2nd Indian Society of Transfusion Medicine (ISTM) annual conference. Asian J Transfus Sci 8(S1):26–87
20.
go back to reference Mollison PL, Engelfriet CP, Contreras M (1997) Blood transfusion in clinical medicine. Blackwell Science, Oxford, England Mollison PL, Engelfriet CP, Contreras M (1997) Blood transfusion in clinical medicine. Blackwell Science, Oxford, England
23.
go back to reference Yasuda H, Ohto H, Sakuma S, Ishikawa Y (2005) Secondary anti-D immunization by Del red blood cells. Transfusion 45(10):1581–1584CrossRefPubMed Yasuda H, Ohto H, Sakuma S, Ishikawa Y (2005) Secondary anti-D immunization by Del red blood cells. Transfusion 45(10):1581–1584CrossRefPubMed
25.
go back to reference Chou ST, Evans P, Vege S, Coleman SL, Friedman DF, Keller M et al (2018) RH genotype matching for transfusion support in sickle cell disease. Blood 132(11):1198–1207CrossRefPubMed Chou ST, Evans P, Vege S, Coleman SL, Friedman DF, Keller M et al (2018) RH genotype matching for transfusion support in sickle cell disease. Blood 132(11):1198–1207CrossRefPubMed
Metadata
Title
Analysis of Rhesus (Rh) Antigen Distributions in Donors and Multi-transfused Patients for Phenotype-Matched Transfusion
Authors
Yuhong Zhao
Ni Yao
Yan Lv
Dawei Cui
Jue Xie
Publication date
08-07-2023
Publisher
Springer India
Published in
Indian Journal of Hematology and Blood Transfusion / Issue 1/2024
Print ISSN: 0971-4502
Electronic ISSN: 0974-0449
DOI
https://doi.org/10.1007/s12288-023-01676-9

Other articles of this Issue 1/2024

Indian Journal of Hematology and Blood Transfusion 1/2024 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine